Belite Bio Statistics
Total Valuation
Belite Bio has a market cap or net worth of $2.00 billion. The enterprise value is $1.86 billion.
Important Dates
The next confirmed earnings date is Wednesday, May 14, 2025, before market open.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Belite Bio has 32.28 million shares outstanding. The number of shares has increased by 14.83% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 32.28M |
| Shares Change (YoY) | +14.83% |
| Shares Change (QoQ) | +2.52% |
| Owned by Insiders (%) | 1.41% |
| Owned by Institutions (%) | 1.06% |
| Float | 14.73M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 13.53 |
| P/TBV Ratio | 13.73 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 24.31, with a Debt / Equity ratio of 0.00.
| Current Ratio | 24.31 |
| Quick Ratio | 24.09 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,999.80 |
Financial Efficiency
Return on equity (ROE) is -30.60% and return on invested capital (ROIC) is -21.04%.
| Return on Equity (ROE) | -30.60% |
| Return on Assets (ROA) | -20.26% |
| Return on Invested Capital (ROIC) | -21.04% |
| Return on Capital Employed (ROCE) | -27.38% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.45M |
| Employee Count | 25 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Belite Bio has paid $6,000 in taxes.
| Income Tax | 6,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +47.42% in the last 52 weeks. The beta is -1.48, so Belite Bio's price volatility has been lower than the market average.
| Beta (5Y) | -1.48 |
| 52-Week Price Change | +47.42% |
| 50-Day Moving Average | 62.17 |
| 200-Day Moving Average | 59.22 |
| Relative Strength Index (RSI) | 54.31 |
| Average Volume (20 Days) | 24,264 |
Short Selling Information
| Short Interest | 72,906 |
| Short Previous Month | 60,691 |
| Short % of Shares Out | 0.49% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.94 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -40.00M |
| Pretax Income | -31.62M |
| Net Income | -36.14M |
| EBITDA | -39.83M |
| EBIT | -40.00M |
| Earnings Per Share (EPS) | -$1.18 |
Full Income StatementBalance Sheet
The company has $145.15 million in cash and $537,000 in debt, giving a net cash position of $144.61 million or $4.48 per share.
| Cash & Cash Equivalents | 145.15M |
| Total Debt | 537,000 |
| Net Cash | 144.61M |
| Net Cash Per Share | $4.48 |
| Equity (Book Value) | 145.82M |
| Book Value Per Share | 4.58 |
| Working Capital | 141.02M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$29.23 million and capital expenditures -$116,000, giving a free cash flow of -$29.35 million.
| Operating Cash Flow | -29.23M |
| Capital Expenditures | -116,000 |
| Free Cash Flow | -29.35M |
| FCF Per Share | -$0.91 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |